U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Structurally Diverse
Created
by admin
on Sat Dec 16 00:03:11 GMT 2023
Edited
by admin
on Sat Dec 16 00:03:11 GMT 2023
Source Materials Class ORGANISM
Source Materials Type PROTIST
Source Materials State LIVE
Organism Family Plasmodiidae
Organism Genus Plasmodium
Organism Species falciparum
Author WELCH
Development Stage ASEXUAL
Part WHOLE
Record UNII
536WV61NML
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Plasmodium falciparum
Common Name English
P. falciparum
Common Name English
Code System Code Type Description
FDA UNII
536WV61NML
Created by admin on Sat Dec 16 00:03:12 GMT 2023 , Edited by admin on Sat Dec 16 00:03:12 GMT 2023
PRIMARY
NCBI TAXONOMY
5833
Created by admin on Sat Dec 16 00:03:12 GMT 2023 , Edited by admin on Sat Dec 16 00:03:12 GMT 2023
PRIMARY
WIKIPEDIA
Plasmodium falciparum
Created by admin on Sat Dec 16 00:03:12 GMT 2023 , Edited by admin on Sat Dec 16 00:03:12 GMT 2023
PRIMARY
Related Record Type Details
RTS,S
VACCINE ANTIGEN->TARGET ORGANISM
Structure of DIFORMYLDAPSONE
INHIBITOR->TARGET ORGANISM
Structure of PRIMAQUINE
INHIBITOR->TARGET ORGANISM
MEPLAZUMAB
INHIBITOR->TARGET ORGANISM
INHIBITOR OF CD
Structure of AQ-13 FREE BASE
INHIBITOR->TARGET ORGANISM
Structure of DESETHYLAMODIAQUINE
INHIBITOR->TARGET ORGANISM
EC50
Structure of AMODIAQUINE
INHIBITOR->TARGET ORGANISM
Activity dependent on strain
EC50
Structure of LUMEFANTRINE
INHIBITOR->TARGET ORGANISM
Structure of PYRONARIDINE
INHIBITOR->TARGET ORGANISM
Structure of DSM-265
INHIBITOR->TARGET ORGANISM
DSM265 displayed maximum antimalarial effects at 3 × EC50 and above, requiring a 24- to 48-hour lag phase before parasite killing. At 1 × EC50, DSM265 parasite killing was further delayed (96-hour lag phase).
EC50
Structure of Sutidiazine
INHIBITOR->TARGET ORGANISM
Structure of GANAPLACIDE
INHIBITOR->TARGET ORGANISM
Structure of CHLOROQUINE
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
IC50
Structure of CHLOROQUINE
INHIBITOR->TARGET ORGANISM
Chloroquine resistant strains
IC50
Structure of ARTENIMOL
INHIBITOR->TARGET ORGANISM
Structure of CIPARGAMIN
INHIBITOR->TARGET ORGANISM
Structure of GANCIDIN W
INHIBITOR->TARGET ORGANISM
Structure of ARTESUNATE
INHIBITOR->TARGET ORGANISM
IC50
Structure of QUISINOSTAT
INHIBITOR->TARGET ORGANISM
Structure of CYCLOGUANIL
INHIBITOR->TARGET ORGANISM
Structure of GSK-369796
INHIBITOR->TARGET ORGANISM
Structure of Cabamiquine
INHIBITOR->TARGET ORGANISM
Structure of ARTEFENOMEL
INHIBITOR->TARGET ORGANISM
PLASMODIUM FALCIPARUM SPOROZOITE NF54 STRAIN (GAMMA IRRADIATED)
VACCINE ANTIGEN->TARGET ORGANISM
Structure of ARTEMISONE
INHIBITOR->TARGET ORGANISM
Structure of MMV-048
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
Structure of ALBITIAZOLIUM
INHIBITOR->TARGET ORGANISM
Structure of ARTEROLANE
INHIBITOR -> TARGET
EC50
Structure of UCT-943
INHIBITOR->TARGET ORGANISM
Whole-cell blood stage activity of UCT943 against a panel of resistant P. falciparum strains to determine potential for cross-resistance compared with MMV048, chloroquine (CQ) and artesunate (AS)
IC50
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966